In a retrospective analysis of patients with peripheral artery disease from a single-payer system, endovascular revascularization was associated with fewer costs than open surgery or primary ...

To investigate the feasibility, efficacy, and safety of endovascular recanalization for symptomatic chronic internal carotid artery occlusions (ICAO). Thirty patients with symptomatic chronic ICAO ...

WASHINGTON — A multidimensional approach to endovascular revascularization along with new therapies will improve treatment of patients with critical limb ischemia, according to a speaker at the ...

In patients with acute ischemic stroke undergoing contemporary endovascular therapy, timely treatment and achievement of successful revascularization are key to good functional outcome and reduced ...

Among patients with peripheral artery disease and intermittent claudication (cramping pain in the legs due to poor circulation in the arteries, aggravated by walking), a combination therapy of ...

DALLAS, TX—The combination of endovascular revascularization plus supervised exercise therapy in patients with peripheral artery disease (PAD) and intermittent claudication results in greater ...

Atherosclerotic renal artery stenosis (RAS) is relatively common and often associated with hypertension and progressive renal insufficiency. Technical improvements of interventional endovascular tools ...

Long Beach, Calif. – May 3, 2024 – New clinical results highlight the need for inclusive approaches and comprehensive examinations of treatment options for peripheral artery disease (PAD), including ...

New analysis of chronic limb-threatening ischemia (CLTI) treatment outcomes was presented today as late-breaking clinical research at the Society for Cardiovascular Angiography & Interventions (SCAI) ...

Currently, there is no consensus on the most effective medical therapy for posterior circulation ischemia. To date, there have been no randomized trials studying the use of different antiplatelet ...

SAN JOSE, Calif., September 29, 2025--(BUSINESS WIRE)--AngioSafe ® today announced its emergence from stealth with 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its flagship ...